Cargando…
Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation
For success in clinical trials, eliminating inclusion of patients with irreversible recovery is important. The purpose of this study was to identify the patient population who do not survive for more than 3 days. A total of 449 patients with sepsis suspected of having disseminated intravascular coag...
Autores principales: | Iba, Toshiaki, Arakawa, Makoto, Ohchi, Yoshifumi, Arai, Takao, Sato, Koichi, Wada, Hideo, Levy, Jerrold H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714842/ https://www.ncbi.nlm.nih.gov/pubmed/30198317 http://dx.doi.org/10.1177/1076029618797474 |
Ejemplares similares
-
Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin
por: Iba, Toshiaki, et al.
Publicado: (2018) -
The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2023) -
Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey
por: Iba, Toshiaki, et al.
Publicado: (2014) -
Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day
Mortality in Patients With Sepsis-Associated Disseminated Intravascular
Coagulation
por: Iba, Toshiaki, et al.
Publicado: (2019) -
Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)